CSI Market
Sign In | Register

Anaptysbio Inc (ANAB) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ANAB quarterly Cash Flow →
Tracking cash flow results across Anaptysbio Inc to Dec 31 2021 helps illustrate how Dec 31 2025's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-13.23
Depreciation & amortization0.56
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation36.07
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Sharebased Compensation And Issuance Of Stock And Warrants For Services Or Claims-
Operating Lease Right Of Use Asset Amortization Expense1.86
Gain Loss On Disposal Of Property And Equipment Net Of Gain On Lease Termination-
Increase Decrease In Operating Lease Liability-1.93
Income taxes0.00
Unrealized Gain (Loss) on Investments-4.73
Increase (Decrease) in Income Taxes Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-87.33
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.61
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities86.81
Discontinued operations0.00
Net Cash flow from Operating Activities19.70
Investing Activities
Capital Expenditures-0.09
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities424.53
Payments to Acquire Available-for-sale Securities, Debt-196.41
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities228.03
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-54.37
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1.45
Payments For Proceeds From Stock Issuance Costs-
Proceeds From Sale Of Advance Future Royalties-
Payments Of Advance Future Royalties Issuance Costs-
Advance Future Royalties Payments-
Advance Future Royalty And Milestone Payments-
Repayment Of Advance Future Royalty And Milestones-76.80
Proceeds From Issuance Of Public Offering-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-132.61
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow19.61
Total Cash Flow115.12
4 historic quarters locked

Sign in to unlock the full Anaptysbio Inc cash flow history.

Sign In Create Free Account

About Anaptysbio Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-088290

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License